Antimicrobial Resistance Monitoring in Veterinary Bacteria
Official title: Antimicrobial Resistance Monitoring of Bacterial Pathogens of Veterinary Concern
Funded at Washington State University · NIH-11400198 · Data updated 2026-11-12
A national effort to track drug-resistant bacteria in animals to protect animal health and reduce risks to people through food or contact.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington State University NIH-funded |
| Lab location | 1 site (Pullman, United States) |
| Project start | July 1, 2018 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $75,000 |
| NIH project number | 5U18FD006453-09 |
| Project ID | NIH-11400198 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are veterinary diagnostic labs and facilities that routinely handle clinically relevant bacterial isolates from animals.
✕Less likely to help
Animals or humans not connected to diagnostic laboratories contributing data may not benefit directly.
What this research studies
This project helps animal health labs collect and standardize data on resistant bacteria from pets and livestock. It will develop and validate whole-genome sequencing methods and improve data analysis pipelines so we can accurately identify resistance patterns. The goal is to generate reliable AMR information that informs treatment decisions in veterinary practice and safeguards human health. Participation may involve veterinary diagnostic labs contributing samples and data over several years.
Why it matters
Potential benefit: If successful, it could improve how we monitor and respond to antimicrobial resistance in animals, reducing the spread of resistance to humans.
How similar studies have gone: AMR monitoring efforts exist and have advanced surveillance, but this project addresses data gaps and method standardization in veterinary settings.
Where this research is happening
-
Washington State University
Pullman, United States Active
Researchers
- Principal investigator: Burbick, Claire R — Washington State University
- Study coordinator: Burbick, Claire R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.